Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
Published Online: 2023-01-?
Journal: The Lancet OncologyLoading...
Authors: Alessandro Gozzetti•Andrea Capra•Angelo Belotti•Angelo Palmas•Barbara Gamberi•Claudia Cellini•Daniela Oddolo•Delia Rota-Scalabrini•Elena Zamagni•Francesca Fioritoni•Francesca Gay•Iolanda Donatella Vincelli•Laura Paris•Luca Bertamini•Luca De Rosa•Mariella Grasso•Mario Boccadoro•Michele Cea•Nicola Giuliani•Norbert Pescosta•Paolo de Fabritiis•Pellegrino Musto•Roberto Mina•Sara Aquino•Sonia Ronconi•Stelvio Ballanti•Vincenzo Pavone
